Company Sees Mid-Single Digit Annual Sales Growth
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 04 2026
0mins
Should l Buy SGI?
Sees mid-single digit annual sales growth and mid-teen annual adjusted EBITDA growth. Comments taken from the company's Investor Day event.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SGI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SGI
Wall Street analysts forecast SGI stock price to rise
7 Analyst Rating
5 Buy
2 Hold
0 Sell
Moderate Buy
Current: 79.150
Low
86.00
Averages
98.60
High
110.00
Current: 79.150
Low
86.00
Averages
98.60
High
110.00
About SGI
Somnigroup International Inc. is a bedding company. The Company is engaged in the business of designing, manufacturing, distributing and retailing. Its portfolio of product brands includes various brands, including Tempur-Pedic, Sealy and Stearns & Foster. Its portfolio of retail brands includes Mattress Firm Dreams, Tempur-Pedic retail stores, SOVA and a variety of other retail brands internationally, which operate in various countries. The Company operates in three segments: Tempur Sealy North America, Tempur Sealy International and Mattress Firm. It distributes through two channels in each operating business segment: Wholesale and Direct. Its Wholesale channel consists of third-party retailers, including third-party distribution, hospitality and healthcare. Its Direct channel includes Company-owned stores, online and call centers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
National Sleep Foundation Partners with Tempur-Pedic to Research Sleep Disruptions in America
- Research Collaboration Launched: The National Sleep Foundation (NSF) has partnered with Tempur-Pedic to combine nationally representative research with SleepTracker-AI® data, aiming to gain insights into the factors disrupting Americans' sleep, thereby providing data-driven support for improving sleep health.
- Data Integration Analysis: This research will merge subjective and objective data to reveal how different demographics, regions, and sleep habits affect sleep quality, assisting in the development of targeted solutions to address the growing sleep issues.
- Sleep Awareness Week Campaign: Tempur-Pedic, as a Gold sponsor of NSF's 2026 Sleep Awareness Week, will enhance public awareness of the importance of sleep health, with an anticipated reach to millions of Americans.
- Long-term Commitment: Since its establishment in 1990, NSF has been dedicated to improving health and well-being through sleep education and advocacy, while Tempur-Pedic leverages its industry-leading innovations to advance its mission of enhancing sleep globally.
See More
Tempur-Pedic Partners with NSF to Enhance Sleep Insights
- Research Collaboration: Tempur-Pedic is partnering with the National Sleep Foundation to combine national survey data with insights from the Sleeptracker-AI® system, aiming to explore the factors affecting sleep quality among Americans, thereby providing a scientific basis for improving sleep health.
- Technological Advantage: Through its partnership with Fullpower-AI®, Tempur-Pedic has secured exclusive rights to the Sleeptracker-AI technology until 2036, ensuring ongoing access to advanced sleep data analysis and coaching, which further solidifies its leadership position in sleep technology.
- Scientific Validation: The Sleeptracker-AI platform has been validated in collaboration with Stanford University's Division of Sleep Medicine, demonstrating accurate measurement of sleep stages and continuity, which distinguishes it from many consumer sleep technologies and enhances brand credibility.
- Sleep Awareness Promotion: As a gold sponsor of the National Sleep Foundation's Sleep Awareness Week, Tempur-Pedic actively promotes the importance of sleep health, aiming to leverage upcoming research findings to help consumers better understand and improve their sleep quality.
See More
Somnigroup International Reports Significant Q4 Net Income Growth
- Net Income Surge: Somnigroup International's net income for Q4 rose significantly to $140.8 million from $71.9 million last year, indicating strong market performance that is likely to boost investor confidence.
- Earnings Per Share Increase: The company's earnings per share jumped from $0.40 to $0.66, surpassing analysts' expectations of $0.72, reflecting a notable improvement in profitability that may attract more investor interest.
- Adjusted EBITDA Growth: Adjusted EBITDA increased from $219.4 million to $348.5 million, demonstrating significant progress in operational efficiency and cost control, which enhances the sustainability of future profits.
- Sales Revenue Surge: Net sales soared from $1.21 billion to $1.87 billion, representing over a 55% increase, which not only boosts market share but also lays a solid foundation for future expansion.
See More
U.S. Markets Rose on Tuesday, with AeroVironment Leading the Gains
U.S. Stock Market Performance: Stock indexes in the U.S. saw an increase on Tuesday, indicating a positive market trend.
Index Gains: The S&P 500 rose by 0.14%, the Dow Jones increased by 0.10%, and the Nasdaq gained 0.07%.
See More
SGI Reports Record Q4 Performance with 55% Sales Growth
- Sales Performance Surge: Somnigroup International Inc (NYSE:SGI) achieved record net sales of $1.9 billion in Q4 2025, representing a 55% year-over-year increase, highlighting the company's strong market performance and growth potential.
- Significant EBITDA Increase: Adjusted EBITDA reached $349 million, up approximately 59%, demonstrating the company's success in cost control and operational efficiency, further solidifying its leadership position in the global bedding industry.
- International Market Growth: International sales grew by 13% on a reported basis and 9% on a constant currency basis, indicating the effectiveness of SGI's global expansion strategy despite competitive pressures.
- Optimistic Future Outlook: The company anticipates adjusted EPS guidance for 2026 to be between $3 and $3.40, with a target EPS of $5.15 for 2028, reflecting SGI's confidence in future market conditions and strategic growth planning.
See More
Somnigroup International Reports Record Q4 2025 Earnings and Strong Growth Outlook
- Record Performance: Somnigroup International achieved net sales of $1.9 billion in Q4 2025, reflecting a robust year-over-year increase of approximately 55%, while adjusted EBITDA rose to $349 million, up about 59%, indicating strong market performance and enhanced profitability.
- Significant Synergies: The company anticipates delivering $225 million in total EBITDA synergies, with $125 million from cost synergies and $100 million from sales synergies, demonstrating substantial progress in cost control and revenue growth through the integration of Mattress Firm.
- Successful Product Launch: The newly launched Sealy Posturepedic line is described as the largest product launch in the company's history, with over 65,000 floor samples shipped, driving meaningful sales growth and reinforcing its leadership position in the U.S. market.
- International Growth: The international segment delivered low double-digit sales growth in Q4, outperforming the broader industry in a challenging market environment, showcasing Somnigroup's expansion potential and competitive advantages in global markets.
See More
National Sleep Foundation Partners with Tempur-Pedic to Research Sleep Disruptions in America
- Research Collaboration Launched: The National Sleep Foundation (NSF) has partnered with Tempur-Pedic to combine nationally representative research with SleepTracker-AI® data, aiming to gain insights into the factors disrupting Americans' sleep, thereby providing data-driven support for improving sleep health.
- Data Integration Analysis: This research will merge subjective and objective data to reveal how different demographics, regions, and sleep habits affect sleep quality, assisting in the development of targeted solutions to address the growing sleep issues.
- Sleep Awareness Week Campaign: Tempur-Pedic, as a Gold sponsor of NSF's 2026 Sleep Awareness Week, will enhance public awareness of the importance of sleep health, with an anticipated reach to millions of Americans.
- Long-term Commitment: Since its establishment in 1990, NSF has been dedicated to improving health and well-being through sleep education and advocacy, while Tempur-Pedic leverages its industry-leading innovations to advance its mission of enhancing sleep globally.
See More
Tempur-Pedic Partners with NSF to Enhance Sleep Insights
- Research Collaboration: Tempur-Pedic is partnering with the National Sleep Foundation to combine national survey data with insights from the Sleeptracker-AI® system, aiming to explore the factors affecting sleep quality among Americans, thereby providing a scientific basis for improving sleep health.
- Technological Advantage: Through its partnership with Fullpower-AI®, Tempur-Pedic has secured exclusive rights to the Sleeptracker-AI technology until 2036, ensuring ongoing access to advanced sleep data analysis and coaching, which further solidifies its leadership position in sleep technology.
- Scientific Validation: The Sleeptracker-AI platform has been validated in collaboration with Stanford University's Division of Sleep Medicine, demonstrating accurate measurement of sleep stages and continuity, which distinguishes it from many consumer sleep technologies and enhances brand credibility.
- Sleep Awareness Promotion: As a gold sponsor of the National Sleep Foundation's Sleep Awareness Week, Tempur-Pedic actively promotes the importance of sleep health, aiming to leverage upcoming research findings to help consumers better understand and improve their sleep quality.
See More
Somnigroup International Reports Significant Q4 Net Income Growth
- Net Income Surge: Somnigroup International's net income for Q4 rose significantly to $140.8 million from $71.9 million last year, indicating strong market performance that is likely to boost investor confidence.
- Earnings Per Share Increase: The company's earnings per share jumped from $0.40 to $0.66, surpassing analysts' expectations of $0.72, reflecting a notable improvement in profitability that may attract more investor interest.
- Adjusted EBITDA Growth: Adjusted EBITDA increased from $219.4 million to $348.5 million, demonstrating significant progress in operational efficiency and cost control, which enhances the sustainability of future profits.
- Sales Revenue Surge: Net sales soared from $1.21 billion to $1.87 billion, representing over a 55% increase, which not only boosts market share but also lays a solid foundation for future expansion.
See More
U.S. Markets Rose on Tuesday, with AeroVironment Leading the Gains
U.S. Stock Market Performance: Stock indexes in the U.S. saw an increase on Tuesday, indicating a positive market trend.
Index Gains: The S&P 500 rose by 0.14%, the Dow Jones increased by 0.10%, and the Nasdaq gained 0.07%.
See More
SGI Reports Record Q4 Performance with 55% Sales Growth
- Sales Performance Surge: Somnigroup International Inc (NYSE:SGI) achieved record net sales of $1.9 billion in Q4 2025, representing a 55% year-over-year increase, highlighting the company's strong market performance and growth potential.
- Significant EBITDA Increase: Adjusted EBITDA reached $349 million, up approximately 59%, demonstrating the company's success in cost control and operational efficiency, further solidifying its leadership position in the global bedding industry.
- International Market Growth: International sales grew by 13% on a reported basis and 9% on a constant currency basis, indicating the effectiveness of SGI's global expansion strategy despite competitive pressures.
- Optimistic Future Outlook: The company anticipates adjusted EPS guidance for 2026 to be between $3 and $3.40, with a target EPS of $5.15 for 2028, reflecting SGI's confidence in future market conditions and strategic growth planning.
See More
Somnigroup International Reports Record Q4 2025 Earnings and Strong Growth Outlook
- Record Performance: Somnigroup International achieved net sales of $1.9 billion in Q4 2025, reflecting a robust year-over-year increase of approximately 55%, while adjusted EBITDA rose to $349 million, up about 59%, indicating strong market performance and enhanced profitability.
- Significant Synergies: The company anticipates delivering $225 million in total EBITDA synergies, with $125 million from cost synergies and $100 million from sales synergies, demonstrating substantial progress in cost control and revenue growth through the integration of Mattress Firm.
- Successful Product Launch: The newly launched Sealy Posturepedic line is described as the largest product launch in the company's history, with over 65,000 floor samples shipped, driving meaningful sales growth and reinforcing its leadership position in the U.S. market.
- International Growth: The international segment delivered low double-digit sales growth in Q4, outperforming the broader industry in a challenging market environment, showcasing Somnigroup's expansion potential and competitive advantages in global markets.
See More
